|
|
|
|
Scientific Publications
|
| |
|
| Publications |
| |
Dhand, A. K., Summers, R.W.: Effects of Acute obstruction in Conscious Dogs on Intestinal Electromyogram. (Abstract presented at meeting of the American Federation for Clinical Research, November 6 – 8, 1980, Chicago, Ill.) |
| |
Dhand, A.K., LaBrecque, D.R. Metzger, J.: Sulindac (clinoril) hepatitis. (Paper Accepted for Publication by Gastroenterology, September 23, 1980) |
| |
LaBrecque, D.R., Dhand, A.K.: Risk of Hepatitis B (HB) Transmission from Staff to Patient in A hemodialysis Unit – An Overrated Problem? (Abstract presented at meeting of the American Association for the Study of Liver Diseases, November 7 – 9, 1980. |
| |
Summers, R.W., Dhand, A.K., Kreel, L., Wingate D.L.: Electromyographic Patterns in Acute Intestinal Obstruction. ( Abstract presented at meeting of the American Motility Society, October 27 – 28, 1980, Tuscon, Arizona and published in the Digestive Disease and Sciences, Vol. 25, No 9, September 1980, p.732. |
| |
5. LaBrecque, D.R., Dhand, A.K.: Risk of Hepatitis B (HB) Transmission from Staff to Patient in a Hempdyalisis Unit—An Overrated Problem? Hepatology, Vol 1, No. 5, p. 398, 1981. |
| |
| Investigational Drug Studies |
|
Famotidine Dyspepsia Study # 143 |
|
Omeprazole DO Retreatment Study # 009-27 |
|
Intron A. Ribavarin Hep C Protocol R 97-023 |
|
Constipation – Predominant Irritable Bowel Sydrome Study # DEX – MD – 02A |
|
Randomized, double-blind, placebo controlled study of Adalimumab for induction and maintenance of clinical remission in subjects with Crohn’s Disease Abbott Protocol # M04-404 |
|
Adalimumab long term safety and tolerability of repeated administration of Adalimumab in subjects with Crohn’s Deisease Abbott Protocol # M04-690 |
|
Open- label, extension study of the safety and efficacy of 25mg or 50mg of OPC—6535 oral tablets in the treatment subjects with Ulcerative Colitis Otsuka Protocol # 197-02-219. |
| |
|
